Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hamblin

Showing results (51-60 of 264) with videos related to

Pageof 27
Sort By:
Leukemia Research|September 26, 2006
Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiencyTerry J Hamblin
Journal of Social Hygiene|March 19, 2010
The problems of the occupation soldierD J HAMBLIN
Drugs|May 23, 2001
Achieving optimal outcomes in chronic lymphocytic leukaemiaT J Hamblin
Lancet (London, England)|November 18, 1972
Cancer researchT J Hamblin
Lancet (London, England)|March 24, 1973
Differentiation of iron deficiency from thalassemia trait by routine blood-countT J Hamblin
Leukemia & Lymphoma|June 20, 2007
ZAP-70 levels do change in CLL but not very oftenTerry J Hamblin
Leukemia Research|June 1, 1995
1st International Conference on Reversal of Multidrug Resistance in Cancer. St. Gallen, Switzerland, 1-3 September 1994T J Hamblin
Seminars in Hematology|April 1, 1996
Immunological abnormalities in myelodysplastic syndromesT J Hamblin
British Medical Journal (Clinical Research Ed.)|June 18, 1983
Blood counts and economicsT J Hamblin
Leukemia Research|January 1, 1991
E. Donnall Thomas, M.D. Nobel laureate 1990T J Hamblin
Pageof 27

Showing results (51-60 of 264) with videos related to

Sort By:
Pageof 27
Leukemia Research|September 26, 2006
Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiencyTerry J Hamblin
Journal of Social Hygiene|March 19, 2010
The problems of the occupation soldierD J HAMBLIN
Drugs|May 23, 2001
Achieving optimal outcomes in chronic lymphocytic leukaemiaT J Hamblin
Lancet (London, England)|November 18, 1972
Cancer researchT J Hamblin
Lancet (London, England)|March 24, 1973
Differentiation of iron deficiency from thalassemia trait by routine blood-countT J Hamblin
Leukemia & Lymphoma|June 20, 2007
ZAP-70 levels do change in CLL but not very oftenTerry J Hamblin
Leukemia Research|June 1, 1995
1st International Conference on Reversal of Multidrug Resistance in Cancer. St. Gallen, Switzerland, 1-3 September 1994T J Hamblin
Seminars in Hematology|April 1, 1996
Immunological abnormalities in myelodysplastic syndromesT J Hamblin
British Medical Journal (Clinical Research Ed.)|June 18, 1983
Blood counts and economicsT J Hamblin
Leukemia Research|January 1, 1991
E. Donnall Thomas, M.D. Nobel laureate 1990T J Hamblin
Pageof 27